Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine
This is the fourth Special Issue in Pharmaceuticals within the last six years dealing with aspects of radiopharmaceutical sciences. It demonstrates the significant interest and increasing relevance to ameliorate nuclear medicine imaging with PET or SPECT, and also radiotherapeutical procedures.Numer...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2019
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04242naaaa2201189uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_60492 | ||
| 005 | 20210212 | ||
| 020 | |a books978-3-03921-314-6 | ||
| 020 | |a 9783039213139 | ||
| 020 | |a 9783039213146 | ||
| 024 | 7 | |a 10.3390/books978-3-03921-314-6 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Reischl, Gerald |4 auth | |
| 245 | 1 | 0 | |a Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
| 300 | |a 1 electronic resource (214 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This is the fourth Special Issue in Pharmaceuticals within the last six years dealing with aspects of radiopharmaceutical sciences. It demonstrates the significant interest and increasing relevance to ameliorate nuclear medicine imaging with PET or SPECT, and also radiotherapeutical procedures.Numerous targets and mechanisms have been identified and have been under investigation over the previous years, covering many fields of medical and clinical research. This development is well illustrated by the articles in the present issue, including 13 original research papers and one review, covering a broad range of actual research topics in the field of radiopharmaceutical sciences. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 653 | |a n/a | ||
| 653 | |a pretargeting | ||
| 653 | |a radioiodination | ||
| 653 | |a neurodegeneration | ||
| 653 | |a phosphoramidon | ||
| 653 | |a GRPR | ||
| 653 | |a molecular imaging | ||
| 653 | |a allosteric modulator | ||
| 653 | |a radiosynthesis | ||
| 653 | |a separation | ||
| 653 | |a ?-CIT. | ||
| 653 | |a PET/CT imaging | ||
| 653 | |a technetium-99m | ||
| 653 | |a gastrin-releasing peptide receptor | ||
| 653 | |a metabotropic glutamate receptor subtype 5 | ||
| 653 | |a glutamate | ||
| 653 | |a oncogenic fusions | ||
| 653 | |a Fusarinine C | ||
| 653 | |a hypoxia | ||
| 653 | |a tirapazamine (TPZ) | ||
| 653 | |a 68Ga | ||
| 653 | |a sentinel lymph node | ||
| 653 | |a 99mTc-radioligand | ||
| 653 | |a iodine-131 | ||
| 653 | |a electrophilic radioiodination | ||
| 653 | |a 4-dioxide (BTDO) | ||
| 653 | |a minigastrin | ||
| 653 | |a ceftriaxone | ||
| 653 | |a tropomyosin receptor kinase | ||
| 653 | |a carbonic anhydrase IX | ||
| 653 | |a ABP688 | ||
| 653 | |a NPY(Y1)R | ||
| 653 | |a MMPEP | ||
| 653 | |a radiosensitizer | ||
| 653 | |a neprilysin-inhibition | ||
| 653 | |a radiochemistry | ||
| 653 | |a girentuximab | ||
| 653 | |a benzotriazine-1 | ||
| 653 | |a gallium-68 | ||
| 653 | |a cholecystokinin-2 receptor | ||
| 653 | |a tumor targeting | ||
| 653 | |a radioimmunotherapy | ||
| 653 | |a salivary gland uptake | ||
| 653 | |a metabolic stability | ||
| 653 | |a tumor hypoxia | ||
| 653 | |a multimerization | ||
| 653 | |a oxidizing agent | ||
| 653 | |a neuroinflammation | ||
| 653 | |a gastrin-releasing peptide | ||
| 653 | |a dextran | ||
| 653 | |a carbon-11 | ||
| 653 | |a peptide heterodimers | ||
| 653 | |a apparent molar activity | ||
| 653 | |a radiometals | ||
| 653 | |a microglia | ||
| 653 | |a rituximab | ||
| 653 | |a [18F]FMISO | ||
| 653 | |a [11C]meta-hydroxyephedrine | ||
| 653 | |a Iodo-Gen® | ||
| 653 | |a mannose | ||
| 653 | |a 177Lu-radiopharmaceuticals | ||
| 653 | |a azomycin nucleosides | ||
| 653 | |a breast cancer | ||
| 653 | |a click chemistry | ||
| 653 | |a small animal imaging | ||
| 653 | |a SR 4317 | ||
| 653 | |a benzotriazine-1-monoxide (BTMO) | ||
| 653 | |a bombesin | ||
| 653 | |a prostate cancer | ||
| 653 | |a Chloramine T | ||
| 653 | |a 99mTc-radiopharmaceuticals | ||
| 653 | |a ketamine | ||
| 653 | |a PSMA-617 | ||
| 653 | |a positron emission tomography | ||
| 653 | |a hydrazinonicotinic acid (HYNIC) | ||
| 653 | |a renal cell carcinomas | ||
| 653 | |a [18F]PSS232 | ||
| 653 | |a PET | ||
| 653 | |a endoradiotherapy | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/1555 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/60492 |7 0 |z DOAB: description of the publication |